Cloning, expression and characterization of recombinant human Fc receptor like 1, 2 and 4 molecules

Iranian Journal of Biotechnology

Volumn 11, Issue 3, 2013, Pages 182-192

  Shabani, Mahdi ^a,b   Hemmati, Azam ^a   Zandemami, Mahdi ^a   Khoshnoodi, Jalal ^c   Jeddi Tehrani, Mahmood ^a   Rabbani, Hodjatallah ^a,d   Amirghofran, Zahra ^b   Shokri, Fazel ^a,c  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

FCRL; His tag; Polyclonal antibody; Protein expression; Purification

Indexed keywords

BACTERIUM LYSATE; FC RECEPTOR; FC RECEPTOR LIKE 1; FC RECEPTOR LIKE 2; FC RECEPTOR LIKE 4; ISOPROPYL 1 THIO BETA DEXTRO GALACTOSIDE; MONOCLONAL ANTIBODY; NITRILOTRIACETATE NICKEL; POLYCLONAL ANTIBODY; POLYHISTIDINE TAG; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERIAL STRAIN; ESCHERICHIA COLI; EXPRESSION VECTOR; EXTRACELLULAR SPACE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOREGULATION; INCUBATION TEMPERATURE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REACTION OPTIMIZATION;

BACTERIA (MICROORGANISMS); PROKARYOTA;

EID: 84883046666     PISSN: 17283043     EISSN: None     Source Type: Journal    
DOI: 10.5812/ijb.9950     Document Type: Article

References (20)

1. Kurosaki T. Regulation of BCR signaling. Mol Immunol. 2011;48(11):1287-91.
2. Leu CM, Davis RS, Gartland LA, Fine WD, Cooper MD. FcRH1: an activation coreceptor on human B cells. Blood. 2005;105(3):1121-6.
3. Jackson TA, Haga CL, Ehrhardt GR, Davis RS, Cooper MD. FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells. J Immunol. 2010;185(12):7405-12.
4. Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci U S A. 2003;100(23):13489-94.
5. Davis RS, Ehrhardt GR, Leu CM, Hirano M, Cooper MD. An extended family of Fc receptor relatives. Eur J Immunol. 2005;35(3):674-80.
6. Du X, Nagata S, Ise T, Stetler-Stevenson M, Pastan I. FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins. Blood. 2008;111(1):338-43.
7. Kazemi T, Asgarian-Omran H, Hojjat-Farsangi M, Shabani M, Memarian A, Sharifian RA, et al. Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int J Cancer. 2008;123(9):2113-9.
8. Davis RS, Dennis G, Jr, Odom MR, Gibson AW, Kimberly RP, Burrows PD, et al. Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev. 2002;190:123-36.
9. Schreeder DM, Cannon JP, Wu J, Li R, Shakhmatov MA, Davis RS. Cutting edge: FcR-like 6 is an MHC class II receptor. J Immunol. 2010;185(1):23-7.
10. Davis RS. Fc receptor-like molecules. Annu Rev Immunol. 2007;25:525-60.
11. Campbell JA, Davis RS, Lilly LM, Fremont DH, French AR, Carayannopoulos LN. Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. J Immunol. 2010;185(1):28-32.
12. Falini B, Tiacci E, Pucciarini A, Bigerna B, Kurth J, Hatzivassiliou G, et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood. 2003;102(10):3684-92.
13. Won WJ, Foote JB, Odom MR, Pan J, Kearney JF, Davis RS. Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. J Immunol. 2006;177(10):6815-23.
14. Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, Davis RS, et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med. 2005;202(6):783-91.
15. Polson AG, Zheng B, Elkins K, Chang W, Du C, Dowd P, et al. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int Immunol. 2006;18(9):1363-73.
16. Haga CL, Ehrhardt GR, Boohaker RJ, Davis RS, Cooper MD. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc Natl Acad Sci U S A. 2007;104(23):9770-5.
17. Laage R, Langosch D. Strategies for prokaryotic expression of eukaryotic membrane proteins. Traffic. 2001;2(2):99-104.
18. Sorensen HP, Mortensen KK. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol. 2005;115(2):113-28.
19. Geisse S, Gram H, Kleuser B, Kocher HP. Eukaryotic expression systems: a comparison. Protein Expr Purif. 1996;8(3):271-82.
20. Yin J, Li G, Ren X, Herrler G. Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J Biotechnol. 2007;127(3):335-47.